Cargando…

O054 What Measure of CPAP Treatment is most closely Associated with Reduced Risk of Future Major Cardiovascular Events (MACE)?

INTRODUCTION: Obstructive sleep apnoea (OSA) is associated with future Major Adverse Cardiovascular Events (MACE). Continuous positive airway pressure (CPAP) is the standard treatment for OSA, but it is not known which measure of CPAP treatment is most closely associated with reduction in future MAC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynor, A, Singh, B, Maddison, K, Eastwood, P, Shenoy, B, Walsh, J, Harvey, C, Dhaliwal, S, McArdle, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591731/ http://dx.doi.org/10.1093/sleepadvances/zpad035.054

Ejemplares similares

O006 Major adverse cardiovascular events in severe Obstructive Sleep Apnoea: Associations with symptom subtypes and symptom burden
por: Shenoy, B, et al.
Publicado: (2023)

P119 CPAP and adverse cardiovascular events in OSA: Are participants of randomized trials representative of sleep clinic patients?
por: Reynor, A, et al.
Publicado: (2021)

O022 Long-term cardiovascular risk in obstructive sleep apnoea: a sleep clinic cohort study
por: Shenoy, B, et al.
Publicado: (2021)

P054 Two effects of curcumin to Candida albicans
por: Kajiwara, Susumu, et al.
Publicado: (2022)

O054. Osteopathic manipulative treatment of headache in a polytrauma patient: case report
por: Adragna, Vito, et al.
Publicado: (2015)

O074 Does Sleep Duration, Shift work or Sleep Disorder Status Predict Perceived work Performance and Quality of Life in Young Adults?
por: Sansom, K, et al.
Publicado: (2023)

MACE in the Race: A Canadian Perspective on Major Adverse Cardiac Events (MACE) During Running
por: Abrahim, Mohammed
Publicado: (2022)

O054: Surgical site infections (SSI) and risk factors in breast cancer surgery (BCS): French survey surviso 2011
por: Louis, M-Y, et al.
Publicado: (2013)

O054 Genioglossus neural drive and upper airway dilation in people with obstructive sleep apnoea during wakefulness
por: Jugé, L, et al.
Publicado: (2022)

P109 Predicting major adverse cardiovascular events using symptom subtypes of severe obstructive sleep apnoea
por: Shenoy, B, et al.
Publicado: (2022)

Estimating sleep duration: performance of open-source processing of actigraphy compared to in-laboratory polysomnography in the community
por: Sansom, Kelly, et al.
Publicado: (2023)

Poster Sessions 054-249
Publicado: (2004)

O004 The effect of treating OSA with CPAP on mood and sleepiness
por: Tolson, J, et al.
Publicado: (2023)

P103 Associations between sleep regularity, OSA and hypertension in a middle-aged community population
por: Sansom, K, et al.
Publicado: (2022)

Rhinitis induced to mace
por: Sanchez Moreno, Gema Vanesa, et al.
Publicado: (2011)

O071 The performance accuracy of wrist-worn oximetry and its automated output parameters for screening obstructive sleep apnoea in children
por: Ohn, M, et al.
Publicado: (2022)

P124 Chronotype and OSA combine to modify risk of hypertension
por: Sansom, K, et al.
Publicado: (2021)

O015 Upper airway collapsibility measurement under anaesthesia in children: feasibility and utility in predicting perioperative respiratory adverse events
por: Ohn, M, et al.
Publicado: (2021)

Opération piquet PO 2000-054
por: Royer, J P
Publicado: (2000)

P054 Neurotransmitters of Sleep and Wake in Flatworms
por: Omond, S
Publicado: (2023)

O053 Cardio-metabolic Health Effects of CPAP Treatment for Sleep Apnoea during Weight Loss: A Randomised Controlled Pilot Trial.
por: Hoyos, C, et al.
Publicado: (2023)

Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo
por: Walsh, Jennifer H, et al.
Publicado: (2021)

Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
por: Franey, Ericha G, et al.
Publicado: (2020)

Current Progress of Studies of Coronary CT for Risk Prediction of Major Adverse Cardiovascular Event (MACE)
por: Zheng, Jianan, et al.
Publicado: (2021)

O030 Reduction in fall risk markers following CPAP treatment of obstructive sleep apnoea in people over 65 years
por: Stevens, D, et al.
Publicado: (2022)

Dr. Kinglake, on Mr. Mace's Case of Gout
por: Kinglake, Robert
Publicado: (1805)

O051 Comparison of standard CPAP therapy and the RACer airway device for the treatment of obstructive sleep apnoea: A randomised clinical trial
por: Neill, A, et al.
Publicado: (2023)

SAT-054 A Curious Case of Aldosteronoma without Hypertension
por: Das, Lakshmi Mohan Viji, et al.
Publicado: (2019)

PSAT054 Isolated ACTH Deficiency in a Patient on Epoprostenol
por: Riordan, Marianne, et al.
Publicado: (2022)

MACE Exam Cram: Medication Aide Certification Exam
por: Whitenton, Linda
Publicado: (2013)

MACE: model based analysis of ChIP-exo
por: Wang, Liguo, et al.
Publicado: (2014)

The importance of design in nanoarchitectonics: multifractality in MACE silicon nanowires
por: Carapezzi, Stefania, et al.
Publicado: (2019)

The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions
por: Kallis, Constantinos, et al.
Publicado: (2023)

What are the major causes of lower limb amputations in a major Australian teaching hospital? The Queensland Diabetic Foot Innovation Project, 2006 – 2007
por: Lazzarini, Peter A, et al.
Publicado: (2011)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
por: Farshidi, Hossein, et al.
Publicado: (2018)

A prediction model for major adverse cardiovascular events (MACE) in patients with coronavirus disease 2019 (COVID-19)
por: Huang, Dong, et al.
Publicado: (2022)

Retrospective Study of Appropriate Primary Prevention in Postmenopausal Women Presenting with a Major Adverse Cardiovascular Endpoint (MACE)
por: Cieri-Hutcherson, Nicole E., et al.
Publicado: (2022)

Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
por: Marsal, Josep Ramon, et al.
Publicado: (2022)

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
por: Chen, Dongqing, et al.
Publicado: (2023)

LBODP054 Hypogonadism in Diabetes Mellitus: Insulin Resistance, The Connecting Link?
por: Singh, Jaspreet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p0shjcvo9pi0a1rf9sdl8be5vi